Before joining QF R&D as Lead Strategy for Healthcare and Biomedical, Dr Hadi Abderrahim led Qatar Biobank as its managing director. Dr Hadi Abderrahim’s previous experiences range from academic settings (CEPH, Cold spring Harbor, Stanford University) to Biotechnology and Pharmaceutical industry. More than 20 years experience in human genetics and biomarker development, studying the effect of genetic factors on reactions to drugs and personalised medicine. As Head of Genetics and Biomarkers at Merck Serono, a pharmaceutical company based in Geneva, Dr Abderrahim oversaw the strategies for patient stratification in personalized medicine and established a central Biobank based in Italy. Prior to that, as Head of Genetics and Genomics Platforms at Genset in Paris, Dr Abderrahim set up a genetic and genomic platform with application to studying complex traits and diseases and a Pharmacogenetics team devoted to identify responders to drug treatments. He obtained his M.D. speciality in Genetic counseling from Hopital Necker, Paris, and he has a Ph.D. in Human Genetics and an executive MBA from HEC Paris.